The Adaptive Alpha Opportunities ETF (AGOX) is an actively managed exchange-traded fund that pursues capital appreciation by tactically allocating across a broad mix of asset classes. Unlike a conventional index fund that passively mirrors a fixed benchmark, AGOX gives its portfolio managers wide discretion to move among equity ETFs, individual securities, investment-grade fixed income, and derivatives in response to changing market conditions.
An ETF trades on a stock exchange like an individual stock, and AGOX fits into the tactical allocation category within the broader multi-asset fund universe. Investors often follow it for access to a flexible, globally diversified growth strategy managed by professionals rather than by a static set of index rules. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the tactical allocation space.
AGOX's investment objective centers on capital appreciation. To achieve this, the fund invests primarily in ETFs registered under the Investment Company Act of 1940 that are unaffiliated with the fund and hold equity securities of issuers across market capitalizations and countries, including emerging markets. The portfolio may also hold fixed-income securities and use derivative instruments.
The strategy is often described as global go-anywhere, meaning the managers are not confined to a single region, sector, or style. This flexibility allows the fund to concentrate opportunistically in areas such as technology or semiconductors for periods of time, or to reduce risk exposure when conditions warrant. Because the approach combines top-down macroeconomic views with bottom-up security selection, the portfolio's investment strategy can evolve meaningfully from one period to the next.
The fund is issued under the Adaptive ETFs fund family and has been co-managed by Cavalier Investments, LLC and Bluestone Capital Management, LLC. The strategy traces its origins to 2012 and is now offered as an exchange-traded fund on NYSE Arca. In its shareholder reporting, the fund benchmarks its results against the MSCI ACWI Index and the Morningstar Moderate Aggressive Target Risk Index, though its active mandate means performance can diverge substantially from those reference points.
AGOX's portfolio holdings are dynamic, but its equity sleeve has historically favored large, growth-oriented positions. In recent disclosures, the largest holdings have included widely held index and sector ETFs such as the Invesco QQQ Trust (QQQ), the SPDR S&P 500 ETF Trust (SPY), and Select Sector SPDR funds focused on technology, healthcare, and communication services. Individual names such as NVIDIA (NVDA) have also appeared among the top positions, alongside emerging-market ETFs such as the Vanguard FTSE Emerging Markets ETF (VWO).
On a sector exposure basis, technology has typically been the largest weighting, followed by healthcare, communication services, industrials, and financials. The fund also maintains cash and cash-equivalent positions as part of its tactical toolkit, and it may use options and other derivatives for hedging or positioning. The total number of holdings can vary, ranging from roughly 80 to several hundred positions depending on the managers' active decisions and the reporting date.
Because AGOX is actively managed, its expense ratio is a notable feature: the net expense ratio is approximately 1.33%, which is considerably higher than the near-zero fees common among passive, market-cap-weighted index ETFs. This reflects the cost of ongoing research, frequent trading, and tactical rebalancing.
Investors pay attention to AGOX because it offers a professional, all-in-one approach to global growth investing. Rather than selecting a single country or sector fund, an investor can hold one ticker whose managers decide how much to allocate to U.S. equities, emerging markets, cash, or fixed income at any given time. This market position makes the fund potentially useful as a core or satellite holding for those who prefer active oversight over passive index replication.
The fund's flexibility is also a key differentiator. Its mandate to shift between asset classes and regions means it can seek to participate in strong equity markets while having tools to reduce exposure during downturns. For investors who value diversification benefits and are comfortable delegating tactical decisions to an experienced management team, AGOX consolidates what might otherwise require several separate positions.
Several factors are important to understand before investing in AGOX. As an equity-focused fund, it carries full market risk, and its active, growth-leaning posture means it can experience significant drawdowns in equity selloffs. The fund has shown meaningful concentration in technology and other growth sectors at times, which can amplify volatility.
The relatively high expense ratio is another consideration: fees reduce net returns over time and must be overcome by the managers' active decisions. Active management also introduces strategy risk — the possibility that the managers' allocation calls underperform the broader market or the fund's benchmarks. Finally, because AGOX invests globally and may use derivatives, investors are exposed to currency risk, emerging-market risk, and the complexity of options positions, which may not suit every investor's risk tolerance.
In my own analysis, I frequently rely on Tickeron’s AI-powered platforms to quickly filter and compare funds like AGOX against peers based on technical indicators, fundamentals, and trends. This helps surface ideas that align with a given strategy without spending hours on manual review. The AI Screener, for instance, lets users build customizable screens that match personal criteria, making the research process more efficient overall.
The Adaptive Alpha Opportunities ETF stands out as a flexible, actively managed vehicle that blends global equities, ETFs, fixed income, and derivatives under a single ticker. Its go-anywhere mandate, growth-oriented bias, and experienced management team distinguish it from passive index products, while its higher fee and active-management risks require careful consideration. For investors seeking a professionally managed, diversified growth strategy without building and rebalancing a multi-fund portfolio themselves, AGOX remains a notable option in the tactical-allocation landscape.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
AGOX saw its Momentum Indicator move above the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 78 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for AGOX just turned positive on November 04, 2026. Looking at past instances where AGOX's MACD turned positive, the stock continued to rise in 38 of 42 cases over the following month. The odds of a continued upward trend are 90%.
AGOX moved above its 50-day moving average on November 17, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AGOX crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.
Following a +4.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where AGOX advanced for three days, in 259 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Aroon Indicator entered an Uptrend today. In 203 of 227 cases where AGOX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 60 cases where AGOX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGOX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
AGOX broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows